Cure 360: MECP2 Reactivation | Interview with Toni Bedalov, MD, PhD | Rett Syndrome Research Trust

Introducing ACTX 101, a Gene Therapy for Rett Using X Reactivation Technology | RSRTПодробнее

Cure 360: MECP2 Reactivation | Interview with Kyle Fink, PhD | Rett Syndrome Research TrustПодробнее

Cure 360: MECP2 Reactivation | Interview with Shawn Liu, PhD | Rett Syndrome Research TrustПодробнее

Cure 360: Cell Therapy | Interview with Joseph Anderson, PhD | Rett Syndrome Research TrustПодробнее

Together We Cure | Rett Syndrome Research TrustПодробнее

Developing an Epigenetic Therapeutic for MECP2 Reactivation | Rett Syndrome Research TrustПодробнее

CURE 360: Attacking Rett Syndrome from Every Angle | Rett Syndrome Research TrustПодробнее

RNA Editing and Its Potential to Improve Rett Syndrome Symptoms | Rett Syndrome Research TrustПодробнее

Reflections on the SummitПодробнее

Interview with Dr. Ivan Conte at ARVO 2024 (Spanish)Подробнее

Reverse Rett Los Angeles 2022 | Rett Syndrome Research TrustПодробнее

Town Hall: When will there be a cure for Rett syndrome? | Rett Syndrome Research TristПодробнее

How to Repair the Spinal Cord? 🐟 | #Introducing Catherina BeckerПодробнее

A Conversation with Neurogene's Leadership | Rett Syndrome Research TrustПодробнее

Results of the Rett ORCA Study: How Rett Families Are Impacting Clinical Trials | RSRTПодробнее